Spero Therapeutics, Inc. (SPRO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
675 MASSACHUSETTS AVENUE CAMBRIDGE, MA 02139 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 76,333 | 109,107 | 146,402 | 126,906 | 82,045 | 115,443 | |||
| Cash and cash equivalent | 76,333 | 109,107 | 112,584 | 85,209 | 29,730 | 34,080 | |||
| Short-term investments | 33,818 | 41,697 | 52,315 | 81,363 | |||||
| Deferred costs | 316 | ||||||||
| Other undisclosed current assets | 54,875 | 4,463 | 11,470 | 12,239 | 13,369 | 8,460 | |||
| Total current assets: | 131,208 | 113,570 | 157,872 | 139,145 | 95,414 | 124,219 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 4,155 | 5,124 | 6,530 | 7,114 | 4,875 | ✕ | |||
| Property, plant and equipment | 2 | 368 | 1,026 | 1,669 | 2,273 | 2,893 | |||
| Deposits noncurrent assets | 153 | ||||||||
| Other noncurrent assets | 435 | 5,740 | 5,644 | 5,212 | 3,520 | 1,192 | |||
| Other undisclosed noncurrent assets | 46,590 | 311 | 21 | 549 | |||||
| Total noncurrent assets: | 51,182 | 11,232 | 13,200 | 14,306 | 10,689 | 4,787 | |||
| TOTAL ASSETS: | 182,390 | 124,802 | 171,072 | 153,451 | 106,103 | 129,006 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6,048 | 7,319 | 9,136 | 6,361 | 7,989 | 7,325 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 5,884 | 3,918 | 2,630 | 2,379 | ||
| Accounts payable | 1,378 | 617 | 1,101 | 1,155 | 4,147 | 3,603 | |||
| Accrued liabilities | 4,670 | 6,702 | 2,151 | 1,288 | 1,212 | 1,343 | |||
| Deferred revenue | 2,132 | 10,369 | 1,857 | ✕ | |||||
| Debt | 928 | ||||||||
| Deferred rent credit | 229 | ||||||||
| Derivative instruments and hedges, liabilities | 223 | ||||||||
| Other undisclosed current liabilities | 28,973 | 3,961 | 7,677 | 7,982 | 17,746 | 4,541 | |||
| Total current liabilities: | 37,153 | 21,649 | 18,670 | 14,343 | 26,663 | 12,318 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 87 | 96 | 6,111 | 7,068 | 4,866 | ||||
| Long-term debt, excluding current maturities | 87 | 96 | 138 | 177 | 249 | ||||
| Liabilities, other than long-term debt | 14,650 | 27,123 | 8,786 | 833 | |||||
| Deferred revenue | 10,825 | 22,166 | 8,786 | ✕ | |||||
| Deferred rent credit | 833 | ||||||||
| Operating lease, liability | 3,825 | 4,957 | 5,973 | 6,891 | 4,617 | ✕ | |||
| Other undisclosed noncurrent liabilities | 23,606 | 49,216 | (6,891) | ||||||
| Total noncurrent liabilities: | 38,343 | 27,219 | 64,113 | 7,068 | 4,866 | 833 | |||
| Total liabilities: | 75,496 | 48,868 | 82,783 | 21,411 | 31,529 | 13,151 | |||
| Equity | |||||||||
| Equity, attributable to parent | 106,894 | 75,934 | 88,289 | 132,040 | 74,574 | 115,500 | |||
| Preferred stock | 3 | 3 | |||||||
| Common stock | 53 | 52 | 32 | 29 | 19 | 17 | |||
| Additional paid in capital | 497,913 | 489,760 | 455,719 | 409,722 | 273,966 | 254,013 | |||
| Accumulated other comprehensive income (loss) | (2) | (7) | 16 | (28) | |||||
| Accumulated deficit | (391,072) | (413,878) | (367,463) | (277,707) | (199,427) | (138,502) | |||
| Equity, attributable to noncontrolling interest | 355 | ||||||||
| Total equity: | 106,894 | 75,934 | 88,289 | 132,040 | 74,574 | 115,855 | |||
| TOTAL LIABILITIES AND EQUITY: | 182,390 | 124,802 | 171,072 | 153,451 | 106,103 | 129,006 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 103,781 | 53,509 | 18,256 | 9,330 | 18,147 | 3,966 | ||
| Gross profit: | 103,781 | 53,509 | 18,256 | 9,330 | 18,147 | 3,966 | ||
| Operating expenses | (82,300) | (95,706) | (106,227) | (88,443) | (81,363) | (46,772) | ||
| Operating income (loss): | 21,481 | (42,197) | (87,971) | (79,113) | (63,216) | (42,806) | ||
| Nonoperating income (expense) | 3,923 | (4,218) | (1,785) | 833 | 2,291 | 771 | ||
| Investment income, nonoperating | 3,937 | 1,106 | 346 | 401 | 1,328 | |||
| Loss, foreign currency transaction, before tax | (373) | |||||||
| Other nonoperating income (expense) | (14) | (55) | (395) | 432 | 740 | 1,144 | ||
| Interest and debt expense | (3,581) | |||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 373 | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 25,404 | (49,996) | (89,756) | (78,280) | (60,925) | (41,662) | ||
| Other undisclosed income from continuing operations before income taxes | 3,581 | |||||||
| Income (loss) from continuing operations before income taxes: | 25,404 | (46,415) | (89,756) | (78,280) | (60,925) | (41,662) | ||
| Income tax expense | (2,598) | |||||||
| Income (loss) from continuing operations: | 22,806 | (46,415) | (89,756) | (78,280) | (60,925) | (41,662) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (89,756) | (78,280) | (60,925) | (41,662) | |
| Other undisclosed net income | ||||||||
| Net income (loss): | 22,806 | (46,415) | (89,756) | (78,280) | (60,925) | (41,662) | ||
| Other undisclosed net income (loss) attributable to parent | (44) | (20) | 25 | |||||
| Net income (loss) attributable to parent: | 22,806 | (46,415) | (89,800) | (78,300) | (60,900) | (41,662) | ||
| Preferred stock dividends and other adjustments | (549) | |||||||
| Other undisclosed net income available to common stockholders, basic | 92,830 | 44 | 20 | |||||
| Net income (loss) available to common stockholders, diluted: | 22,806 | 46,415 | (89,756) | (78,829) | (60,900) | (41,662) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 22,806 | (46,415) | (89,756) | (78,280) | (60,925) | (41,662) | ||
| Other comprehensive loss | (28) | |||||||
| Comprehensive income (loss): | 22,806 | (46,415) | (89,756) | (78,280) | (60,925) | (41,690) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 2 | 5 | (23) | 44 | ||||
| Comprehensive income (loss), net of tax, attributable to parent: | 22,806 | (46,413) | (89,751) | (78,303) | (60,881) | (41,690) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.